http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-930702318-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
filingDate 1991-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1993-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-930702318-A
titleOfInvention Isoxazole compounds, pharmaceutically acceptable salts thereof and medical uses thereof
abstract The present invention is an isoxazole compound represented by the following General Formula (1); Pharmaceutically acceptable salts thereof; Or its medical application;n n n n n n n n [Wherein R is a hydrogen atom or a lower alkoxy group, R 1 is the following formula (2):n n n n n n n n Wherein A is -NH- or -O-, B is a methylene group or a carbonyl group, m is 0 or 1, n is an integer from 1 to 12, X is a hydrogen atom, a hydroxy group or a lower alkoxycarbonyl group , Y is a phenyl group or a hydrogen atom which may be substituted with one or more halogen atoms, and the following formula (3):n n n n n n n n (Wherein Z is a pyrimidinyl group) or the following formula (4):n n n n n n n n (Wherein R 2 is a styryl group which may be substituted with one or more hydroxy groups).
priorityDate 1990-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1MQ78
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID477753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCK7GQZ4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A6I8R1G6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6QV45
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID240
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25290
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11689
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51399
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID450428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PRG7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID573013
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09917
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48999
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393625

Total number of triples: 41.